CVE-2024-24245 is a local privilege escalation vulnerability identified in ClamXAV, an antivirus software developed by Canimaan Software LTD, specifically affecting versions 3.1.2 through 3.6.1. The vulnerability resides in the ClamXAV helper tool component, which is designed to perform privileged operations on behalf of the main application. Due to improper access control or flawed privilege separation (classified under CWE-250: Execution with Unnecessary Privileges), a local attacker with limited privileges can exploit this flaw to gain elevated privileges on the affected system. The vulnerability does not require user interaction (UI:N) and has a low attack complexity (AC:L), but the attacker must have local access (AV:L) and some privileges (PR:L) to initiate the exploit. The impact is severe, affecting confidentiality, integrity, and availability (C:H/I:H/A:H), meaning an attacker could fully compromise the system, access sensitive data, modify or delete files, or disrupt system operations. The vulnerability was publicly disclosed on April 9, 2024, with no known exploits in the wild at the time of publication. The vendor addressed the issue in ClamXAV version 3.6.2, which users should deploy promptly to remediate the risk. This vulnerability is particularly concerning in environments where ClamXAV is deployed on multi-user systems or systems with sensitive data, as it could allow an attacker to bypass security controls and gain administrative privileges.

The potential impact of CVE-2024-24245 is significant for organizations using vulnerable versions of ClamXAV. Successful exploitation allows a local attacker to escalate privileges, potentially gaining full administrative control over the affected system. This can lead to unauthorized access to sensitive information, modification or destruction of critical files, installation of persistent malware, and disruption of security monitoring or antivirus functions. In enterprise environments, this could facilitate lateral movement, data exfiltration, or sabotage. Since ClamXAV is antivirus software, compromising it undermines the security posture of the entire system, increasing the risk of further attacks. The vulnerability's local attack vector means that initial access is required, but once achieved, the attacker can bypass privilege restrictions, making containment and remediation more challenging. Organizations relying on ClamXAV in sectors such as finance, healthcare, government, and critical infrastructure may face heightened risks due to the sensitivity of their data and the importance of system availability.

To mitigate CVE-2024-24245, organizations should immediately upgrade ClamXAV to version 3.6.2 or later, where the vulnerability is patched. Until the update is applied, restrict local access to systems running vulnerable versions by enforcing strict user account controls and limiting administrative privileges. Employ endpoint detection and response (EDR) solutions to monitor for suspicious local privilege escalation attempts. Regularly audit user permissions and system logs to detect unauthorized privilege changes. Consider implementing application whitelisting to prevent unauthorized execution of helper tools or scripts. Additionally, educate users about the risks of local access compromise and enforce strong physical security controls to prevent unauthorized physical access. For environments where patching is delayed, consider isolating affected systems or using virtualization sandboxing to contain potential exploitation. Maintain up-to-date backups to enable recovery in case of compromise.